Structures of human gastrin-releasing peptide receptors bound to antagonist and agonist for cancer and itch therapy
Proceedings of the National Academy of Sciences · 07.02.2023 · 120 (6)
DOI: 10.1073/pnas.2216230120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023-02. Verfasst von Shuman Peng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hangzhou Institute of Innovative Medicine, Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, C…. Hauptthemen laut MEDLINE: Receptors, Bombesin, Neoplasms. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Science and Technology of the People's Republic of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Gastrin releasing peptide receptor (GRPR), a member of the bombesin (BBN) G protein-coupled receptors, is aberrantly overexpressed in several malignant tumors, including those of the breast, prostate, pancreas, lung, and central nervous system. Additionally, it also mediates non-histaminergic itch and pathological itch conditions in mice. Thus, GRPR could be an attractive target for cancer and itch therapy. Here, we report the inactive state crystal structure of human GRPR in complex with the non-peptide antagonist PD176252, as well as two active state cryo-electron microscopy (cryo-EM) structures of GRPR bound to the endogenous peptide agonist gastrin-releasing peptide and the synthetic BBN analog [D-Phe 6 , β-Ala 11 , Phe 13 , Nle 14 ] Bn (6–14), in complex with G q heterotrimers. These structures revealed the molecular mechanisms for the ligand binding, receptor activation, and G q proteins signaling of GRPR, which are expected to accelerate the structure-based design of GRPR antagonists and agonists for the treatments of cancer and pruritus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hangzhou Institute of Innovative Medicine, Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhej…
- Center for the Study of Itch and Sensory Disorders, Washington University School of Medicine, St Louis, MO 63110.
- Department of Anesthesiology, Washington University School of Medicine, St Louis, MO 63110.
- Department of Medicine, Washington University School of Medicine, St Louis, MO 63110.
- Department of Psychiatry, Washington University School of Medicine, St Louis, MO 63110.
- Department of Developmental Biology, Washington University School of Medicine, St Louis, MO 63110.
ORCID-Profile: Yuting Zhan, Zhou-Feng Chen, Haitao Zhang
Förderung
- Ministry of Science and Technology of the People's Republic of China
- National Natural Science Foundation of China
Zitieren
APA
Peng, S., Zhan, Y., Zhang, D., Ren, L., Chen, A., Chen, Z. F., & Zhang, H. (2023). Structures of human gastrin-releasing peptide receptors bound to antagonist and agonist for cancer and itch therapy. Proceedings of the National Academy of Sciences, 120(6). https://doi.org/10.1073/pnas.2216230120
Vancouver
Peng S, Zhan Y, Zhang D, Ren L, Chen A, Chen ZF, et al. Structures of human gastrin-releasing peptide receptors bound to antagonist and agonist for cancer and itch therapy. Proceedings of the National Academy of Sciences. 2023;120(6). doi:10.1073/pnas.2216230120
BibTeX
@article{Peng2023,
author = {Peng, Shuman and Zhan, Yuting and Zhang, Dongqi and Ren, Lu and Chen, Anqi and Chen, Zhou-Feng and Zhang, Haitao},
title = {Structures of human gastrin-releasing peptide receptors bound to antagonist and agonist for cancer and itch therapy},
journal = {Proceedings of the National Academy of Sciences},
year = {2023},
volume = {120},
number = {6},
doi = {10.1073/pnas.2216230120}
}
EUVIMED